Back

Cardiovascular safety of next-generation BTK inhibitors versus ibrutinib in CLL/SLL: a systematic review and meta-analysis of randomised controlled trials

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardioprotection and cardiovascular safety in contemporary cancer therapies Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Bernardo Temer Teixeira Goldwasser

(Brazil)

4 More presentations in this session

Presentation thumbnail
Distinct blood pressure variability phenotype in VEGF–TKI–induced hypertension: a comparative study across cardio-oncology populations
Doctor H. Yu (Lanzhou, CN)
Abstract Slides Video
Presentation thumbnail
Systematic review and network meta-analysis of cardio-protective therapies in cancer patients
Doctor V. Maharajan (London, GB)
Abstract Slides Video
Presentation thumbnail
Mdivi-1 reduces blood pressure in gastric cancer-bearing nude mice by ameliorating apatinib-induced Drp1-mediated excessive mitochondrial fission
Doctor J. Yu (Lanzhou, CN)
Abstract Slides Video
Presentation thumbnail
Validation of a deep learning–based workflow for echocardiographic interpretation in a cardio-oncology population
Doctor M. Andres (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardioprotection and cardiovascular safety in contemporary cancer therapies

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Atherosclerotic cardiovascular events associated with BTK inhibitors: a systematic review and meta-analysis of harms
20 June 2025
thumbnail
Congress Presentation
Safety of SGLT2-Inhibitors in cardio-oncology patients with heart failure undergoing cancer treatment
21 June 2025
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources